Literature DB >> 24974185

Role of the Keap1-Nrf2 pathway in cancer.

Hanna M Leinonen1, Emilia Kansanen1, Petri Pölönen2, Merja Heinäniemi2, Anna-Liisa Levonen3.   

Abstract

The Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor E2-related factor 2 (Nrf2) pathway is one of the major signaling cascades involved in cell defense and survival against endogenous and exogenous stress. While Nrf2 and its target genes provide protection against various age-related diseases including tumorigenesis, constitutively active Nrf2 in cancer cells increases the expression of cytoprotective genes and, consequently, enhances proliferation via metabolic reprogramming and inhibition of apoptosis. Herein, we review the current understanding of the regulation of Nrf2 in normal cells as well as its dual role in cancer. Furthermore, the mechanisms of Nrf2 dysregulation in cancer, consequences of unchecked Nrf2 activity, and therapies targeting the Keap1-Nrf2 system are discussed.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antioxidants; Cancer; Chemoresistance; Keap1; Metabolic reprogramming; Nrf2; Oxidative stress; Radioresistance

Mesh:

Substances:

Year:  2014        PMID: 24974185     DOI: 10.1016/B978-0-12-420117-0.00008-6

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  58 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

Review 2.  Profiles of Radioresistance Mechanisms in Prostate Cancer.

Authors:  Luksana Chaiswing; Heidi L Weiss; Rani D Jayswal; Daret K St Clair; Natasha Kyprianou
Journal:  Crit Rev Oncog       Date:  2018

Review 3.  Long non-coding RNA functions in lung cancer.

Authors:  Haiwei Sang; Haihong Liu; Peng Xiong; Min Zhu
Journal:  Tumour Biol       Date:  2015-04-21

4.  Protection of Nrf2 against arsenite-induced oxidative damage is regulated by the cyclic guanosine monophosphate-protein kinase G signaling pathway.

Authors:  Chengzhi Chen; Xuejun Jiang; Shiyan Gu; Yanhao Lai; Yuan Liu; Zunzhen Zhang
Journal:  Environ Toxicol       Date:  2016-10-24       Impact factor: 4.119

5.  Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?

Authors:  Lucia Anna Muscarella; Vito Michele Fazio
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 6.  Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors.

Authors:  L Wan; C A Neumann; P R LeDuc
Journal:  Lab Chip       Date:  2020-03-03       Impact factor: 6.799

7.  Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis.

Authors:  Steffan Vartanian; Taylur P Ma; James Lee; Peter M Haverty; Donald S Kirkpatrick; Kebing Yu; David Stokoe
Journal:  Mol Cell Proteomics       Date:  2015-12-28       Impact factor: 5.911

8.  Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.

Authors:  Xiao-Yan Zou; Dong Ding; Na Zhan; Xiao-Ming Liu; Cheng Pan; Yu-Min Xia
Journal:  J Invest Dermatol       Date:  2014-09-03       Impact factor: 8.551

9.  Expression of LC3, LAMP2, KEAP1 and NRF2 in Salivary Adenoid Cystic Carcinoma.

Authors:  Cong-Fa Huang; Wei-Wei Deng; Lu Zhang; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Pathol Oncol Res       Date:  2015-09-08       Impact factor: 3.201

10.  The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.

Authors:  Qian Zuo; Renyi Wu; Xi Xiao; Caizhi Yang; Yuqing Yang; Chao Wang; Lizhu Lin; Ah-Ng Kong
Journal:  J Cell Biochem       Date:  2018-08-20       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.